Romidepsin (FK228) and its analogs directly inhibit phosphatidylinositol 3-kinase activity and potently induce apoptosis as histone deacetylase/phosphatidylinositol 3-kinase dual inhibitors (Q34394171)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Romidepsin (FK228) and its analogs directly inhibit phosphatidylinositol 3-kinase activity and potently induce apoptosis as histone deacetylase/phosphatidylinositol 3-kinase dual inhibitors	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Romidepsin (FK228) and its analogs directly inhibit phosphatidylinositol 3-kinase activity and potently induce apoptosis as histone deacetylase/phosphatidylinositol 3-kinase dual inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Ken Saijo

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Tadashi Katoh

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Hideki Shimodaira

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Akifumi Oda

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Ohgi Takahashi

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Chikashi Ishioka

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

12 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1994-2001

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Phosphoinositide kinases

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

The phosphoinositide 3-kinase pathway

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

High frequency of mutations of the PIK3CA gene in human cancers

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Functional analysis of PIK3CA gene mutations in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Tenets of PTEN tumor suppression

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Advances in development of phosphatidylinositol 3-kinase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Yeast as a screening tool.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Assessment of PTEN tumor suppressor activity in nonmammalian models: the year of the yeast.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Romidepsin: a novel histone deacetylase inhibitor for cancer

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Histone deacetylase inhibitors: molecular mechanisms of action

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Inhibition of PI3K by ZSTK474 suppressed tumor growth not via apoptosis but G0/G1 arrest

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

RNA interference-mediated depletion of phosphoinositide 3-kinase activates forkhead box class O transcription factors and induces cell cycle arrest and apoptosis in breast carcinoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

Total synthesis of the bicyclic depsipeptide HDAC inhibitors spiruchostatins A and B, 5''-epi-spiruchostatin B, FK228 (FR901228) and preliminary evaluation of their biological activity

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12002

21 January 2018

FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22924958

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of phosphatidylinositol 3-kinase/Akt signaling pathway is a determinant of the sensitivity to a novel histone deacetylase inhibitor, FK228, in lung adenocarcinoma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22924958

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pleitropic drug ABC transporters from Saccharomyces cerevisiae.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22924958

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae

1 reference

https://pubmed.ncbi.nlm.nih.gov/22924958

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22924958

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/CAS.12002

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34394171&oldid=1576806072"